<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02617186</url>
  </required_header>
  <id_info>
    <org_study_id>BFCRS-RP-003-1508-31</org_study_id>
    <nct_id>NCT02617186</nct_id>
  </id_info>
  <brief_title>Robotic Lobectomy vs. Thoracoscopic Lobectomy for Early Stage Lung Cancer: RCT</brief_title>
  <official_title>Robotic Lobectomy vs. Thoracoscopic Lobectomy for Early Stage Lung Cancer: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Joseph's Healthcare Hamilton</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Toronto / Toronto General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rouen Normandy University / CHU-Hopitaux de Rouen (Rouen, France)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Joseph's Healthcare Hamilton</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      During video-assisted thoracoscopic lobectomy (VATS), the surgeon inserts a small camera&#xD;
      attached to a thoracoscope that puts the image onto a video screen. Instruments are inserted&#xD;
      via small incisions, and the lung resection is completed. Robotic thoracic surgery (RTS) uses&#xD;
      a similar minimally invasive approach, but the very precise instruments involved with RTS&#xD;
      allow the surgeon to view the lung using 3-dimensional imaging. The instruments give the&#xD;
      surgeons increased range of motion during the surgery, and research demonstrates that RTS has&#xD;
      a less steep learning curve as compared to VATS. Both VATS and RTS demonstrated better&#xD;
      results as compared to traditional thoracotomy (open surgery). However, Robotic lobectomy has&#xD;
      not yet been compared directly to video-assisted thoracoscopic lobectomy (VATS) in a&#xD;
      prospective manner.&#xD;
&#xD;
      There are two major barriers against the widespread adoption of robotic thoracic surgery. The&#xD;
      first barrier is the lack of high-quality prospective data. To our knowledge, there are no&#xD;
      prospective trials comparing VATS to RTS for early stage lung cancer. The second major&#xD;
      barrier to the widespread adoption of robotic technology in thoracic surgery is the perceived&#xD;
      higher cost of Robotic lobectomy. To address these barriers, the investigators will undertake&#xD;
      the first randomized controlled trial comparing Thoracoscopic Lobectomy to Robotic Lobectomy&#xD;
      for early stage lung cancer.&#xD;
&#xD;
      Prospective randomization will eliminate the biases of retrospective data and will serve to&#xD;
      determine whether there exist any advantages to Health Related Quality of life (HRQOL) or&#xD;
      patient outcomes in favour of Robotic Lobectomy over VATS Lobectomy. Furthermore, through a&#xD;
      prospective cost-utility analysis, this trial will provide the highest quality data to&#xD;
      evaluate the true economic impact of robotic technology in thoracic surgery in a Canadian&#xD;
      health system.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">September 2031</completion_date>
  <primary_completion_date type="Actual">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in HRQOL scores at week 12 between the treatment groups</measure>
    <time_frame>12 weeks post-surgery</time_frame>
    <description>Difference in HRQOL scores between the treatment groups, as measured by the EQ-5D-5L questionnaire at week 12.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Short-term clinical outcome differences</measure>
    <time_frame>3 weeks post-surgery</time_frame>
    <description>Clinical staging will be determined from diagnostic imaging reports</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short-term clinical outcome differences</measure>
    <time_frame>3 weeks post-surgery</time_frame>
    <description>Pathological staging will be determined from pathology report</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short-term clinical outcome differences</measure>
    <time_frame>3 weeks post-surgery</time_frame>
    <description>Number of lymph nodes sampled</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short-term clinical outcome differences</measure>
    <time_frame>3 weeks post-surgery</time_frame>
    <description>Admission date</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short-term clinical outcome differences</measure>
    <time_frame>3 weeks post-surgery</time_frame>
    <description>Date of surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short-term clinical outcome differences</measure>
    <time_frame>3 weeks post-surgery</time_frame>
    <description>Discharge date</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short-term clinical outcome differences</measure>
    <time_frame>3 weeks post-surgery</time_frame>
    <description>Chest tube removal date</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short-term clinical outcome differences</measure>
    <time_frame>3 weeks post-surgery</time_frame>
    <description>Intraoperative blood loss</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short-term clinical outcome differences</measure>
    <time_frame>3 weeks post-surgery</time_frame>
    <description>Post-operative analgesia will be determined from list of prescribed pain medications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short-term clinical outcome differences</measure>
    <time_frame>3 weeks post-surgery</time_frame>
    <description>Post-surgical pain will be determined from the Numeric Pain Rating Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resource utilization</measure>
    <time_frame>1 year post-surgery</time_frame>
    <description>Operating room time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resource utilization</measure>
    <time_frame>1 year post-surgery</time_frame>
    <description>Operating room staff</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resource utilization</measure>
    <time_frame>1 year post-surgery</time_frame>
    <description>Surgical instruments and consumables</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resource utilization</measure>
    <time_frame>1 year post-surgery</time_frame>
    <description>Admission to critical care beds</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resource utilization</measure>
    <time_frame>1 year post-surgery</time_frame>
    <description>Hospital length of stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resource utilization</measure>
    <time_frame>1 year post-surgery</time_frame>
    <description>Duration of intravenous analgesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resource utilization</measure>
    <time_frame>1 year post-surgery</time_frame>
    <description>Postoperative complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resource utilization</measure>
    <time_frame>1 year post-surgery</time_frame>
    <description>Costs associated with chronic post-surgical pain up to one year after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost Effectiveness</measure>
    <time_frame>5 years post-surgery</time_frame>
    <description>The incremental cost per quality-adjusted life year (QALY) gained will be calculated to assess cost effectiveness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in HRQOL scores between the treatment groups</measure>
    <time_frame>3, 7 weeks post-surgery; 6 months post-surgery; 1, 1.5, 2, 3, 4, 5 years post-surgery</time_frame>
    <description>Difference in HRQOL scores between the treatment groups, as measured by the EQ-5D-5L questionnaire at weeks 3 and 7; months 6, 12, 18, 24; and years 3, 4, and 5, which coincide with the intervals of oncological surveillance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in 5-year survival rate between the two groups</measure>
    <time_frame>5 years post-surgery</time_frame>
    <description>Difference in 5-year survival rate between the two groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">592</enrollment>
  <condition>Non-small Cell Lung Cancer</condition>
  <condition>Thoracic Surgery</condition>
  <arm_group>
    <arm_group_label>Thoracoscopic Lobectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Robotic Lobectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Video-assisted thoracoscopic surgery</intervention_name>
    <description>patients randomized to this arm will receive video-assisted thoracic surgery (VATS)</description>
    <arm_group_label>Thoracoscopic Lobectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Robotic thoracic surgery</intervention_name>
    <description>patients randomized to this arm will receive robotic thoracic surgery (RTS) with the da Vinci Robot</description>
    <arm_group_label>Robotic Lobectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age &gt;/= 18 years&#xD;
&#xD;
          2. Clinical stage I, II or IIIa non-small cell lung cancer (NSCLC)&#xD;
&#xD;
          3. Candidates for minimally invasive pulmonary lobectomy, as determined by the operating&#xD;
             surgeon.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Clinical stage IIIb or IV NSCLC&#xD;
&#xD;
          2. Not a candidate for minimally invasive surgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Waël C Hanna, MDCM, MBA, FRCSC</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yogita S Patel</last_name>
    <phone>905-522-1155</phone>
    <phone_ext>35096</phone_ext>
    <email>patelys@mcmaster.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>McMaster University / St. Joseph's Healthcare Hamilton</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yogita S Patel</last_name>
      <phone>905-522-1155</phone>
      <phone_ext>35096</phone_ext>
      <email>patelys@mcmaster.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Grogan EL, Jones DR. VATS lobectomy is better than open thoracotomy: what is the evidence for short-term outcomes? Thorac Surg Clin. 2008 Aug;18(3):249-58. doi: 10.1016/j.thorsurg.2008.04.007. Review.</citation>
    <PMID>18831499</PMID>
  </reference>
  <reference>
    <citation>Onaitis MW, Petersen RP, Balderson SS, et al. Thoracoscopic Lobectomy Is a Safe and Versatile Procedure. Transactions of the Meeting of the American Surgical Association. 2006;124:86-91. doi:10.1097/01.sla.0000234892.79056.63.</citation>
  </reference>
  <reference>
    <citation>Veronesi G. Robotic thoracic surgery: technical considerations and learning curve for pulmonary resection. Thorac Surg Clin. 2014 May;24(2):135-41, v. doi: 10.1016/j.thorsurg.2014.02.009. Review.</citation>
    <PMID>24780416</PMID>
  </reference>
  <reference>
    <citation>Nasir BS, Bryant AS, Minnich DJ, Wei B, Cerfolio RJ. Performing robotic lobectomy and segmentectomy: cost, profitability, and outcomes. Ann Thorac Surg. 2014 Jul;98(1):203-8; discussion 208-9. doi: 10.1016/j.athoracsur.2014.02.051. Epub 2014 May 1.</citation>
    <PMID>24793685</PMID>
  </reference>
  <reference>
    <citation>Park BJ, Melfi F, Mussi A, Maisonneuve P, Spaggiari L, Da Silva RK, Veronesi G. Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results. J Thorac Cardiovasc Surg. 2012 Feb;143(2):383-9. doi: 10.1016/j.jtcvs.2011.10.055. Epub 2011 Nov 20.</citation>
    <PMID>22104677</PMID>
  </reference>
  <reference>
    <citation>Wei B, D'Amico TA. Thoracoscopic versus robotic approaches: advantages and disadvantages. Thorac Surg Clin. 2014 May;24(2):177-88, vi. doi: 10.1016/j.thorsurg.2014.02.001. Review.</citation>
    <PMID>24780422</PMID>
  </reference>
  <reference>
    <citation>Louie BE, Farivar AS, Aye RW, Vallières E. Early experience with robotic lung resection results in similar operative outcomes and morbidity when compared with matched video-assisted thoracoscopic surgery cases. Ann Thorac Surg. 2012 May;93(5):1598-604; discussion 1604-5. doi: 10.1016/j.athoracsur.2012.01.067. Epub 2012 Mar 20.</citation>
    <PMID>22440364</PMID>
  </reference>
  <reference>
    <citation>Kent M, Wang T, Whyte R, Curran T, Flores R, Gangadharan S. Open, video-assisted thoracic surgery, and robotic lobectomy: review of a national database. Ann Thorac Surg. 2014 Jan;97(1):236-42; discussion 242-4. doi: 10.1016/j.athoracsur.2013.07.117. Epub 2013 Oct 1.</citation>
    <PMID>24090577</PMID>
  </reference>
  <reference>
    <citation>Paul S, Jalbert J, Isaacs AJ, Altorki NK, Isom OW, Sedrakyan A. Comparative effectiveness of robotic-assisted vs thoracoscopic lobectomy. Chest. 2014 Dec;146(6):1505-1512. doi: 10.1378/chest.13-3032.</citation>
    <PMID>24810546</PMID>
  </reference>
  <reference>
    <citation>Hanna, WC., Fahim, C., Patel, P., Shargall, Y., Waddell TK., Yasufuku, K. (2015). Robotic Pulmonary Resection for Lung Cancer: The First Canadian Series. Abstract Accepted for podium presentation at Canadian Association of Thoracic Surgeons (CATS) 18th Annual Meeting, September 17-20, Quebec, QC.</citation>
  </reference>
  <reference>
    <citation>Merritt RE, Hoang CD, Shrager JB. Lymph node evaluation achieved by open lobectomy compared with thoracoscopic lobectomy for N0 lung cancer. Ann Thorac Surg. 2013 Oct;96(4):1171-1177. doi: 10.1016/j.athoracsur.2013.05.044. Epub 2013 Jul 31.</citation>
    <PMID>23915591</PMID>
  </reference>
  <reference>
    <citation>D'Amico TA, Niland J, Mamet R, Zornosa C, Dexter EU, Onaitis MW. Efficacy of mediastinal lymph node dissection during lobectomy for lung cancer by thoracoscopy and thoracotomy. Ann Thorac Surg. 2011 Jul;92(1):226-31; discussion 231-2. doi: 10.1016/j.athoracsur.2011.03.134.</citation>
    <PMID>21718849</PMID>
  </reference>
  <reference>
    <citation>Research Electronic Data Capture (RedCap). http://www.project-redcap.org</citation>
  </reference>
  <reference>
    <citation>Cerfolio RJ. Total port approach for robotic lobectomy. Thorac Surg Clin. 2014 May;24(2):151-6, v. doi: 10.1016/j.thorsurg.2014.02.006. Review.</citation>
    <PMID>24780418</PMID>
  </reference>
  <reference>
    <citation>EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990 Dec;16(3):199-208.</citation>
    <PMID>10109801</PMID>
  </reference>
  <reference>
    <citation>Cerfolio RJ, Bryant AS. How to teach robotic pulmonary resection. Semin Thorac Cardiovasc Surg. 2013 Spring;25(1):76-82. doi: 10.1053/j.semtcvs.2013.01.004. Review.</citation>
    <PMID>23800532</PMID>
  </reference>
  <reference>
    <citation>Pickard AS, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes. 2007 Dec 21;5:70. Erratum in: Health Qual Life Outcomes. 2010;8:4.</citation>
    <PMID>18154669</PMID>
  </reference>
  <reference>
    <citation>Little, R.J.A. and Rubin, D.B. (1987) Statistical Analysis with Missing Data. J. Wiley &amp; Sons, New York.</citation>
  </reference>
  <reference>
    <citation>SAS Institute Inc., SAS 9.4 Help and Documentation, Cary, NC: SAS Institute Inc., 2000-2012.</citation>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 22, 2015</study_first_submitted>
  <study_first_submitted_qc>November 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2015</study_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>McMaster University</investigator_affiliation>
    <investigator_full_name>Wael Hanna</investigator_full_name>
    <investigator_title>Associate Professor, Departments of Surgery and HEI</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

